Results 181 to 190 of about 64,904 (211)

PKI STANDARDS

2004
openaire   +2 more sources

PKI-587 and Sorafenib Targeting PI3K/AKT/mTOR and Ras/Raf/MAPK Pathways Synergistically Inhibit HCC Cell Proliferation

Journal of Surgical Research, 2012
Roberto Gedaly, B Mark Evers
exaly  

In vivo dynamics and kinetics of pKi-67: Transition from a mobile to an immobile form at the onset of anaphase

Experimental Cell Research, 2005
Ippei Kotera, Masatoshi Takagi
exaly  

PKI Registration

2003
openaire   +1 more source

PKI PERFORMANCE

2004
openaire   +2 more sources

Antitumor Efficacy of PKI-587, a Highly Potent Dual PI3K/mTOR Kinase Inhibitor

Clinical Cancer Research, 2011
Judy Lucas
exaly  

A PKA survival pathway inhibited by DPT-PKI, a new specific cell permeable PKA inhibitor, is induced by T. annulata in parasitized B-lymphocytes

Apoptosis: an International Journal on Programmed Cell Death, 2006
Xavier Cayla, Angelita Rebollo, Gordon Langsley   +2 more
exaly  

PKI DESIGN ISSUES

2004
Luke O’Connor, Douglas Barton, Anthony Moran   +2 more
openaire   +2 more sources

PKI Registration

2002
openaire   +1 more source

Pki Products

2004
openaire   +1 more source